2022
DOI: 10.1016/j.bpc.2021.106739
|View full text |Cite
|
Sign up to set email alerts
|

His-tag β-galactosidase supramolecular performance

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2023
2023
2025
2025

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(2 citation statements)
references
References 50 publications
0
2
0
Order By: Relevance
“…Figure 3a shows the pull-down result of LacZ. As demonstrated in the figure, LacZ was expressed as IBs using LHS1, 0.4 mM IPTG (isopropyl β-d-1-thiogalactopyranoside) for 20 h at 15-20 • C. LacZ monomer has 116 kDa [33]. To obtain active LacZ inclusion bodies, we used the short tag LHS1.…”
Section: Resultsmentioning
confidence: 99%
“…Figure 3a shows the pull-down result of LacZ. As demonstrated in the figure, LacZ was expressed as IBs using LHS1, 0.4 mM IPTG (isopropyl β-d-1-thiogalactopyranoside) for 20 h at 15-20 • C. LacZ monomer has 116 kDa [33]. To obtain active LacZ inclusion bodies, we used the short tag LHS1.…”
Section: Resultsmentioning
confidence: 99%
“…His-tags are convenient: being short, they allow elution in mild native conditions and provide at the same time a reasonable degree of purity. But in some cases placing His-tags at protein’s termini may create problems: a classical hexahistidine sequence can cause protein inclusion body formation , or oligomerization through histidine residues, , can impair catalytic enzyme functions or protein–protein interaction, or His-tags cannot be used at N- or C-termini because of their functional and/or structural importance. In these cases, His-tags could be used in a noncanonical way by inserting them into the polypeptide chain.…”
Section: Introductionmentioning
confidence: 99%